VV

Vedprakash Vyas

Active Director Director DIN 01682158
DIN 01682158 First appointment Nov 2003 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 7 historical roles
Total affiliations 9 Since Nov 2003
Shareholding value •••• Premium profile

About Vedprakash Vyas

Data last updated:

Vedprakash Vyas is a Director at Totus Health Care (India) Limited (since 2013) and Additional Director at Paradigm Medivision Private Limited (since 2020). The companies operate in Pharma and Business Services. The 2 current companies with reported revenue have a combined latest revenue of ₹25.25 Cr; the largest is Totus Health Care (India) Limited at ₹12.64 Cr (FY 2019). Earlier, Vedprakash Vyas was a Director at Kyros Therapeutics (India) Limited (2005–2012) and Director at Sandip Ipr & Legal Services Private Limited (2010–2011) and 5 more.

DIN 01682158
Primary Designation Director
Industry Pharma
First Appointment 04 Nov 2003
Oldest Company Age 32 yrs
Largest company Totus Health Care (India) Limited · ₹12.64 Cr (FY 2019)
Combined revenue ₹25.25 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Totus Health Care (India) Limited U24239TG1994PLC017578
Director20 May 20131994₹12.64 Cr (FY 2019)Active
Paradigm Medivision Private Limited U24239TG2004PTC043554
Additional Director18 Aug 20202004₹12.61 Cr (FY 2019)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kyros Therapeutics (India) Limited U24239TG2005PLC045761
Director30 Mar 20052005Active
Director23 Jun 20102010₹9.8 Lakh (FY 2017)Strike Off
Solana Life Sciences Private Limited U24231MP1999PTC013742
Director25 Jun 20181999₹16.49 Cr (FY 2024)Active
Spectrum Formulation Private Limited U74140MP2005PTC017577
Director12 May 20092005₹42.18 Cr (FY 2025)Active
Director04 Nov 20032003Strike Off
Director19 Oct 20122012₹20.30 Cr (FY 2019)Under Liquidation
Kyros Medicaments Private Limited U24232MP2012PTC029298
Director28 Sep 20122012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Vedprakash Vyas

Directorship timeline

Open interactive timeline →
Ariston Pharma Nova Tech Private Limited
Kyros Medicaments Private Limited
Totus Health Care (India) Limited
Paradigm Medivision Private Limited
Premium access

Shareholding and investment profile for Vedprakash Vyas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vedprakash Vyas

Vedprakash Vyas currently holds 2 directorships: Totus Health Care (India) Limited (Director, since 20 May 2013, revenue ₹12.64 Cr (FY 2019)); Paradigm Medivision Private Limited (Additional Director, since 18 Aug 2020, revenue ₹12.61 Cr (FY 2019)).

Vedprakash Vyas was first appointed on 04 Nov 2003 as Director at Allanthus Biotech And Research Institute Limited. The most recent appointment on record is 18 Aug 2020 at Paradigm Medivision Private Limited.

The 2 current companies of Vedprakash Vyas that report revenue have a combined latest revenue of ₹25.25 Cr: Totus Health Care (India) Limited ₹12.64 Cr (FY 2019); Paradigm Medivision Private Limited ₹12.61 Cr (FY 2019).

Vedprakash Vyas held 7 earlier board appointments: Kyros Therapeutics (India) Limited (Director, 30 Mar 2005 to 15 Mar 2012); Sandip Ipr & Legal Services Private Limited (Director, 23 Jun 2010 to 24 Nov 2011); Solana Life Sciences Private Limited (Director, 25 Jun 2018 to 31 Jul 2018); Spectrum Formulation Private Limited (Director, 12 May 2009 to 25 Nov 2016); Allanthus Biotech And Research Institute Limited (Director, 04 Nov 2003 to 01 May 2011); and 2 more.

The current boards of Vedprakash Vyas's companies include Akhtar Uzzaman (Totus Health Care (India) Limited), Jyothi Vyas (Totus Health Care (India) Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available